Amgen ' s Blockbuster Osteoporosis Drug Prolia Flagged With FDA Strictest Warning

The FDA has added a serious warning to the prescribing information for Amgen Inc’s AMGN drug Prolia (denosumab), emphasizing an increased risk of severely low calcium levels in specific patient groups. Amgen’s Prolia, initially approved in 2010 for treating bone loss in postmenopausal women and…#fda #amgenincs #prolia #amgen #merckcoincs #mrkfosamax #xgeva #evenity #lungcancer
Source: Reuters: Health - Category: Consumer Health News Source Type: news